BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
98.67
+2.61 (2.72%)
Sep 21, 2026, 2:49 PM EDT - Market open

BioNTech SE Stock Forecast

Stock Price Forecast

According to 20 analysts polled by S&P Global, BioNTech SE stock has a consensus rating of "Buy" and an average price target of $118.07. The average 1-year stock price forecast is 19.66% higher than the current stock price, while the lowest is $74.79 (-24.20%) and the highest is $142.69 (+44.61%).

Price Target: $118.07 (+19.66%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$74.79$118.07$124.95$142.69
Change-24.20%+19.66%+26.63%+44.61%

Analyst Ratings

The average analyst rating for BioNTech SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy131314141413
Buy111111
Hold355545
Sell100011
Strong Sell000000
Total181920202020

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Buy
Maintains
$115
BuyMaintains$115+16.55%Sep 21, 2026
UBS
UBS
Buy
Maintains
$135
BuyMaintains$135+36.82%Sep 16, 2026
Berenberg Bank
Berenberg Bank
Buy
Maintains
$132$140
BuyMaintains$132$140+41.89%Sep 16, 2026
Jefferies
Jefferies
Buy
Maintains
$138
BuyMaintains$138+39.86%Sep 15, 2026
BMO Capital
BMO Capital
Hold
Maintains
$105
HoldMaintains$105+6.42%Sep 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.81B
from 2.87B
Decreased by -37.05%
Revenue Next Year
1.81B
from 1.81B
Increased by 0.26%
EPS This Year
-4.65
from -0.48
EPS Next Year
-4.91
from -4.65
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
18.98B17.31B3.82B2.75B2.87B1.81B
Revenue Growth
3,834.63%-8.78%-77.94%-27.96%4.32%-37.05%
Gross Profit
16.07B14.32B3.22B2.21B2.26B1.48B
Gross Margin
84.66%82.70%84.29%80.32%78.70%81.91%
Operating Income
14.85B11.92B971.80M-1.29B-1.27B-1.82B
Net Income
10.29B9.43B930.30M-665.30M-1.14B-1.38B
EPS
-----0.48-4.65
Free Cash Flow
----280.90M-1.75B
No. Analysts
-----18
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High2.2B
Avg1.8B
Low1.7B

Revenue Growth

Revenue Growth202620272028
High
-24.8%
Avg
-37.0%
Low
-42.4%

EPS Forecast

EPS202620272028
High-3.30
Avg-4.65
Low-6.61

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-